Impact of trial design on the estimation of drug potency and power in clinical trials of haemophilia with inhibitors

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Impact of trial design on the estimation of drug potency and power in clinical trials of haemophilia with inhibitors. / Larsen, Malte Selch; Juul, Rasmus Vestergaard; Kreilgaard, Mads; Kristensen, Annemarie T.; Simonsson, Ulrika S. H.

In: European Journal of Pharmaceutical Sciences, Vol. 123, 15.10.2018, p. 531-538.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Larsen, MS, Juul, RV, Kreilgaard, M, Kristensen, AT & Simonsson, USH 2018, 'Impact of trial design on the estimation of drug potency and power in clinical trials of haemophilia with inhibitors', European Journal of Pharmaceutical Sciences, vol. 123, pp. 531-538. https://doi.org/10.1016/j.ejps.2018.07.056

APA

Larsen, M. S., Juul, R. V., Kreilgaard, M., Kristensen, A. T., & Simonsson, U. S. H. (2018). Impact of trial design on the estimation of drug potency and power in clinical trials of haemophilia with inhibitors. European Journal of Pharmaceutical Sciences, 123, 531-538. https://doi.org/10.1016/j.ejps.2018.07.056

Vancouver

Larsen MS, Juul RV, Kreilgaard M, Kristensen AT, Simonsson USH. Impact of trial design on the estimation of drug potency and power in clinical trials of haemophilia with inhibitors. European Journal of Pharmaceutical Sciences. 2018 Oct 15;123:531-538. https://doi.org/10.1016/j.ejps.2018.07.056

Author

Larsen, Malte Selch ; Juul, Rasmus Vestergaard ; Kreilgaard, Mads ; Kristensen, Annemarie T. ; Simonsson, Ulrika S. H. / Impact of trial design on the estimation of drug potency and power in clinical trials of haemophilia with inhibitors. In: European Journal of Pharmaceutical Sciences. 2018 ; Vol. 123. pp. 531-538.

Bibtex

@article{ac1c481724a54d319c76fe271b8c6b20,
title = "Impact of trial design on the estimation of drug potency and power in clinical trials of haemophilia with inhibitors",
keywords = "Haemophilia with inhibitors, Clinical trial design, Repeated time-to-event modelling, Drug potency, Statistical power",
author = "Larsen, {Malte Selch} and Juul, {Rasmus Vestergaard} and Mads Kreilgaard and Kristensen, {Annemarie T.} and Simonsson, {Ulrika S. H.}",
year = "2018",
month = oct,
day = "15",
doi = "10.1016/j.ejps.2018.07.056",
language = "English",
volume = "123",
pages = "531--538",
journal = "Norvegica Pharmaceutica Acta",
issn = "0928-0987",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Impact of trial design on the estimation of drug potency and power in clinical trials of haemophilia with inhibitors

AU - Larsen, Malte Selch

AU - Juul, Rasmus Vestergaard

AU - Kreilgaard, Mads

AU - Kristensen, Annemarie T.

AU - Simonsson, Ulrika S. H.

PY - 2018/10/15

Y1 - 2018/10/15

KW - Haemophilia with inhibitors

KW - Clinical trial design

KW - Repeated time-to-event modelling

KW - Drug potency

KW - Statistical power

U2 - 10.1016/j.ejps.2018.07.056

DO - 10.1016/j.ejps.2018.07.056

M3 - Journal article

C2 - 30077714

VL - 123

SP - 531

EP - 538

JO - Norvegica Pharmaceutica Acta

JF - Norvegica Pharmaceutica Acta

SN - 0928-0987

ER -

ID: 208889719